Did You Acquire Blaize Common Stock Between July 17, 2025 and August 13, 2026 or Pursuant or Traceable to the Offering Materials Issued in Connection with Blaize’s May 2026 Public Offering?

A securities class action has been filed on behalf of all persons and entities who purchased or otherwise acquired Blaize Holdings, Inc. (“Blaize” or the “Company”) (NASDAQ: BZAI) common stock between July 17, 2025 and August 13, 2026, inclusive (the “Class Period”) and all persons and entities who purchased or otherwise acquired Blaize common stock pursuant or traceable to the Offering Materials issued in connection with Blaize’s May 2026 public offering.

The action, Alyahya v. Blaize Holdings, Inc., et al., Case No. 2:26-cv-10609, was filed on September 17, 2026 in the U.S. District Court for the Central District of California. The action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, and Sections 11, 12(a)(2), and 15 of the Securities Act of 1933.

What Does the Complaint Allege?

The complaint alleges that Defendants made materially false and/or misleading statements concerning Blaize’s agreements with Starshine Computing Power Technology Limited and NeoTensr and the extent to which those agreements supported Blaize’s revenue projections.

Specifically, the complaint alleges that: (1) Starshine was an unproven counterparty and there was substantial uncertainty whether it had the resources and operational capacity to fully perform under the Starshine agreement; (2) there was substantial uncertainty whether NeoTensr had the resources and operational capacity to issue purchase orders sufficient to generate the anticipated $50 million in first-year revenue; (3) as of March 31, 2026, 53% of Blaize’s accounts receivable were more than 90 days past due and two customers located in China, with subsequent disclosures indicating that those customers were Starshine and NeoTensr, accounted for approximately 93.3% of the Company’s accounts receivable; (4) Blaize had not secured the inventory needed for an anticipated NeoTensr delivery despite statements concerning that inventory; and (5) as a result, Defendants allegedly lacked a reasonable basis for representing that Blaize would achieve its full-year 2026 revenue guidance.

The complaint further alleges that the offering materials for Blaize’s May 2026 public offering contained materially inaccurate statements and omissions concerning Blaize’s receivables and the Starshine and NeoTensr agreements, including that Blaize had not secured the inventory needed for the anticipated NeoTensr delivery. In the offering, Blaize sold 18,918,918 shares of common stock at $1.85 per share.

BZAI Stock Declines Following August 13 Disclosure

The complaint alleges that the truth was finally revealed after the market closed on August 13, 2026, when Blaize reduced its full-year 2026 revenue outlook from $130 million to $40-$43 million, citing commercial opportunities that did not convert into orders and higher supply-chain costs. Blaize also disclosed that Starshine’s $8.8 million receivable remained outstanding and that it did not expect further purchase orders from Starshine.

According to the complaint, Blaize common stock fell from $1.17 per share on August 13, 2026 to $0.59 per share on August 14, 2026, a decline of nearly 50% in one day.

October 5, 2026 Lead Plaintiff Deadline

The deadline to seek appointment as lead plaintiff is October 5, 2026. You do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

Blaize Investors: Contact Kehoe Law Firm

If you purchased or otherwise acquired Blaize common stock during the Class Period or pursuant or traceable to the May 2026 public offering, and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss your potential legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Did You Purchase or Otherwisw Acquire Ardelyx Common Stock Between January 13, 2025 and August 6, 2026?

A securities class action has been filed on behalf of investors who purchased or otherwise acquired Ardelyx, Inc. (“Ardelyx” or the “Company”)(NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the “Class Period”).

The action, Broadwater v. Ardelyx, Inc., et al., Case No. 1:26-cv-14270, was filed on September 17, 2026 in the U.S. District Court for the District of Massachusetts. The action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

What Does the Complaint Allege?

The complaint alleges that Defendants made positive statements about Ardelyx’s commercial growth and its ability to achieve projected revenue guidance and long-term growth targets for IBSRELA and XPHOZAH while making materially false and misleading statements and/or concealing material adverse facts concerning the true state of the products’ commercial performance and growth prospects.

Specifically, the complaint alleges that Ardelyx was facing increasing payer-related access and reimbursement barriers, including more stringent prior authorization requirements and step-edit requirements, that slowed new-patient starts and delayed prescription fulfillment. The complaint further alleges that Defendants continued to tout commercial growth and sustained product demand while minimizing increasing payer and access hurdles affecting IBSRELA and uncertainty surrounding XPHOZAH’s ability to achieve its long-term growth targets.

ARDX Stock Declines Following August 6 Disclosure

The complaint alleges that the truth emerged after the market closed on August 6, 2026, when Ardelyx reported that IBSRELA revenue was below expectations due to significantly increased utilization-management processes from payors. Ardelyx cut its full-year 2026 IBSRELA revenue guidance from $410-$430 million to $350-$370 million and withdrew its long-term XPHOZAH revenue guidance.

According to the complaint, Ardelyx’s common stock fell from a closing price of $4.87 per share on August 6, 2026 to $4.00 per share on August 7, 2026, a decline of approximately 18% in one day.

November 16, 2026 Lead Plaintiff Deadline

The deadline to seek appointment as lead plaintiff is November 16, 2026. You do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

Ardelyx Investors: Contact Kehoe Law Firm

If you purchased or otherwise acquired Ardelyx common stock during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss your potential legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Did You Purchase or Otherwise Acquire AppLovin Securities Between February 12, 2026 and August 5, 2026?

A securities class action has been filed on behalf of investors who purchased or otherwise acquired securities of AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) between February 12, 2026 and August 5, 2026, inclusive (the “Class Period”).

The action is captioned Talbot v. AppLovin Corporation, et al., Case No. 3:26-cv-10584, and was filed on September 16, 2026 in the U.S. District Court for the Northern District of California. The action seeks to recover damages caused by Defendants’ alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

What Does the AppLovin Securities Class Action Allege?

The complaint alleges that during the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) the generative AI video creative feature for AppLovin Ads was subject to significant development delays, making its release on the Company’s timeline unlikely; (2) Defendants overstated the constancy with which AppLovin was improving its AI models; and (3) for these reasons, among others, AppLovin significantly overstated the benefits and reliability of the purported “virtuous cycle” and “compounding” value proposition that its AI models provided to customers and the Company. As a result, Defendants’ public statements were allegedly materially false and misleading.

APP Stock Declines Following Disclosures

July 13, 2026: According to the complaint, a Bank of America Securities analyst published a note reporting softer-than-expected e-commerce ad growth for June and raising concerns about the rollout of AppLovin Ads to all advertisers. Following publication of the note, AppLovin’s stock price fell $64.13 per share, or 12.65%, to close at $442.85 per share.

August 5, 2026: According to the complaint, AppLovin reported second-quarter revenue of $1.92 billion, below consensus estimates of $1.94 billion. During the earnings call, Defendants stated that the pace of meaningful model improvement was “lighter than normal during the quarter” and that the generative AI video tool was still a “work in progress.” AppLovin’s stock price subsequently fell $82.13 per share, or 19.66%, to close at $335.67 per share on August 6, 2026.

November 16, 2026 Lead Plaintiff Deadline

The deadline to seek appointment as lead plaintiff is November 16, 2026. You do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

AppLovin Investors: Contact Kehoe Law Firm

If you purchased or otherwise acquired AppLovin securities during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss your potential legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Did You Purchase Doximity Common Stock Between August 8, 2024 and May 13, 2026?

A securities class action has been filed on behalf of investors who purchased or otherwise acquired common stock of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) between August 8, 2024 and May 13, 2026, inclusive (the “Class Period”).

The action is captioned Michigan Laborers’ Pension Fund v. Doximity, Inc., et al., Case No. 3:26-cv-10529, and was filed on September 16, 2026 in the U.S. District Court for the Northern District of California. The action seeks to recover damages caused by Defendants’ alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

What Does the Doximity Securities Class Action Allege?

The complaint alleges that, during the Class Period, Defendants made materially false and misleading statements and failed to disclose that: (1) Doximity overstated the impact its Newsfeed had on revenue growth; (2) Doximity was losing market share to competitors with more favorable pricing and engagement models; and (3) despite statements emphasizing “deep engagement,” Doximity relied on banner ads and email newsletters as advertising methods. The complaint alleges that these undisclosed facts rendered Defendants’ positive statements about Doximity’s business and competitive position materially false or misleading.

DOCS Stock Declines Following Disclosures

November 6, 2025: Doximity expressed caution regarding the outlook for advertising spending and implied a slowdown in sales growth in the second half of fiscal 2026. The complaint alleges that Doximity common stock declined $8.29 per share, or 13%, following the disclosures.

February 5, 2026: Doximity lowered its fiscal 2026 revenue guidance and announced that sales growth had decelerated while net income had contracted. The complaint alleges that Doximity common stock declined $5.59 per share, or 17%.

May 13, 2026: Doximity announced that it had missed its already-reduced revenue guidance and projected significantly slower growth for fiscal 2027. The complaint alleges that Doximity common stock declined an additional $5.38 per share, or 23%, from a May 13 closing price of $23.39 to $18.01 on May 14, 2026.

November 16, 2026 Lead Plaintiff Deadline

The deadline to seek appointment as lead plaintiff is November 16, 2026.  You do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

Doximity Investors: Contact Kehoe Law Firm

If you purchased or otherwise acquired Doximity common stock during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss your potential legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Did You Purchase or Otherwise Acquire Baidu Securities Between November 18, 2025 and August 17, 2026?

A securities class action has been filed on behalf of investors who purchased or otherwise acquired securities of Baidu, Inc. (“Baidu” or the “Company”) (NASDAQ: BIDU), including call options, between November 18, 2025 and August 17, 2026, inclusive (the “Class Period”), and who were damaged thereby.

The action is captioned Rosewood Funeral Home Inc. v. Baidu, Inc., et al., Case No. 1:26-cv-08012, and was filed on September 14, 2026 in the U.S. District Court for the Southern District of New York. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

What Does the Complaint Allege?

The complaint alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had overstated the ability of its AI business to mitigate rapid declines in its legacy online marketing business; (2) as a result, the Company’s revenue was reasonably likely to decline; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

BIDU Stock Declines Following Disclosures

The complaint alleges that on February 26, 2026, Baidu reported fourth-quarter and full-year 2025 financial results showing year-over-year revenue declines. Baidu ADS fell $7.50 per share, or 5.65%, to close at $125.15 per share that day.

The complaint further alleges that on August 18, 2026, Baidu reported second-quarter 2026 results showing continued declines in its legacy business and a quarter-over-quarter decline in its Core AI-powered business. Baidu ADS fell $13.25 per share, or 12.73%, to close at $90.87 per share that day.

November 13, 2026 Lead Plaintiff Deadline

The deadline to seek appointment as lead plaintiff is November 13, 2026. You do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

Baidu Investors: Contact Kehoe Law Firm

If you purchased or otherwise acquired Baidu securities, including call options, between November 18, 2025 and August 17, 2026, inclusive, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form  or send us a message to discuss your potential legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Did You Purchase or Otherwise Acquire AST SpaceMobile Securities Between March 4, 2025 and July 15, 2026?

A securities class action has been filed on behalf of investors who purchased or otherwise acquired securities of AST SpaceMobile, Inc. (“AST SpaceMobile” or the “Company”) (NASDAQ: ASTS) between March 4, 2025 and July 15, 2026, inclusive (the “Class Period”).

The action is captioned Hunter v. AST SpaceMobile, Inc., et al., Case No. 7:26-cv-00378, and was filed on September 14, 2026 in the U.S. District Court for the Western District of Texas, Midland/Odessa Division. The action seeks to recover damages caused by Defendants’ alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

What Does the Complaint Allege?

The complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) AST SpaceMobile’s increasing capital requirements were likely to increase the Company’s debt load and share dilution with greater frequency and at greater scale than Defendants had signaled to investors; (2) Defendants overstated the sufficiency of the Company’s capital and liquidity position to achieve its strategic and business goals; (3) Defendants overstated the durability of AST SpaceMobile’s competitive position in the satellite direct-to-cellular market and, even following the EchoStar Transaction, continued overstating the Company’s competitive position; (4) AST SpaceMobile was experiencing slow user adoption in the U.S. and Japan; and (5) the foregoing was likely to have a significant negative impact on the Company’s business and financial prospects.

ASTS Stock Declines Following Disclosures

The complaint alleges that the truth about AST SpaceMobile’s business and financial prospects emerged through a series of disclosures during the Class Period. On January 6, 2026, Scotiabank downgraded AST SpaceMobile to a “Sell” recommendation, citing, among other things, significant competition from Starlink and evidence of slow user adoption in the U.S. and Japan. AST SpaceMobile’s Class A common stock price fell $11.76 per share, or 12.06%, to close at $85.73 per share on January 7, 2026.

The complaint further alleges that on July 15, 2026, AST SpaceMobile announced its intent to offer another $1.0 billion aggregate principal amount of convertible senior notes due 2034, with an option to purchase up to an additional $150 million aggregate principal amount of notes. Following the disclosures, AST SpaceMobile’s Class A common stock price fell $11.30 per share, or 17.04%, to close at $55.01 per share on July 16, 2026.

November 13, 2026 Lead Plaintiff Deadline

The deadline to seek appointment as lead plaintiff is November 13, 2026. You do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

AST SpaceMobile Investors: Contact Kehoe Law Firm

If you purchased or otherwise acquired AST SpaceMobile securities between March 4, 2025 and July 15, 2026, inclusive, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form  or send us a message to discuss your potential legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]